Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
Clover Health Investments, Corp. (Nasdaq: CLOV), a physician enablement technology company focused on Medicare, has announced its participation in the 2024 Wells Fargo Healthcare Conference. Peter Kuipers, the company's Chief Financial Officer, is scheduled to present on Wednesday, September 4, 2024, at 4:30 p.m. Eastern Time.
Investors and interested parties can access a live webcast of the presentation through Clover Health's investor relations website. Additionally, a replay of the presentation will be made available on the same platform for those unable to attend the live event. This conference participation provides an opportunity for Clover Health to showcase its commitment to improving healthcare access for Medicare beneficiaries.
Clover Health Investments, Corp. (Nasdaq: CLOV), una società tecnologica abilitante per i medici con focus su Medicare, ha annunciato la sua partecipazione alla Conferenza Sanitaria Wells Fargo 2024. Peter Kuipers, il Chief Financial Officer dell'azienda, è programmato per presentare mercoledì 4 settembre 2024, alle 16:30 ora orientale.
Investitori e parti interessate possono accedere a un webcast dal vivo della presentazione tramite il sito delle relazioni con gli investitori di Clover Health. Inoltre, una registrazione della presentazione sarà disponibile sulla stessa piattaforma per coloro che non possono partecipare all'evento dal vivo. Questa partecipazione alla conferenza offre a Clover Health l'opportunità di mostrare il proprio impegno nel migliorare l'accesso alla sanità per gli aventi diritto a Medicare.
Clover Health Investments, Corp. (Nasdaq: CLOV), una empresa de tecnología habilitadora para médicos centrada en Medicare, ha anunciado su participación en la Conferencia de Atención Médica de Wells Fargo 2024. Peter Kuipers, el Director Financiero de la empresa, está programado para presentar el miércoles 4 de septiembre de 2024, a las 4:30 p.m. hora del Este.
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través del sitio web de relaciones con inversores de Clover Health. Además, se hará disponible una repetición de la presentación en la misma plataforma para aquellos que no puedan asistir al evento en vivo. Esta participación en la conferencia proporciona a Clover Health una oportunidad para mostrar su compromiso con mejorar el acceso a la atención médica para los beneficiarios de Medicare.
Clover Health Investments, Corp. (Nasdaq: CLOV)는 Medicare에 집중하는 의사 지원 기술 회사로, 2024 웰스 파고 헬스케어 컨퍼런스에 참가한다고 발표했습니다. Peter Kuipers 회사의 최고재무책임자는 2024년 9월 4일 수요일 동부 표준시 오후 4시 30분에 발표할 예정입니다.
투자자 및 이해 관계자는 Clover Health의 투자자 관계 웹사이트를 통해 실시간 웹캐스트에 접속할 수 있습니다. 또한, 라이브 이벤트에 참석할 수 없는 사람들을 위해 같은 플랫폼에서 발표의 재방송도 제공될 예정입니다. 이 컨퍼런스 참여는 Clover Health가 Medicare 수혜자를 위한 의료 접근 개선에 대한 의지를 보여줄 수 있는 기회를 제공합니다.
Clover Health Investments, Corp. (Nasdaq: CLOV), une entreprise de technologie habilitante pour les médecins axée sur Medicare, a annoncé sa participation à la Conférence sur les soins de santé Wells Fargo 2024. Peter Kuipers, le directeur financier de l'entreprise, est prévu pour présenter le mercredi 4 septembre 2024 à 16h30, heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site de relations avec les investisseurs de Clover Health. De plus, un enregistrement de la présentation sera disponible sur la même plateforme pour ceux qui ne peuvent pas assister à l'événement en direct. Cette participation à la conférence offre à Clover Health l'opportunité de démontrer son engagement à améliorer l'accès aux soins de santé pour les bénéficiaires de Medicare.
Clover Health Investments, Corp. (Nasdaq: CLOV), ein Technologieunternehmen zur Unterstützung von Ärzten mit Fokus auf Medicare, hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 angekündigt. Peter Kuipers, der Finanzvorstand des Unternehmens, wird am Mittwoch, den 4. September 2024, um 16:30 Uhr Eastern Time präsentieren.
Investoren und Interessierte können die Live-Übertragung der Präsentation über die Investor-Relations-Website von Clover Health verfolgen. Außerdem wird eine Aufzeichnung der Präsentation auf derselben Plattform verfügbar sein, für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können. Die Teilnahme an dieser Konferenz bietet Clover Health die Möglichkeit, sein Engagement für die Verbesserung des Zugangs zur Gesundheitsversorgung für Medicare-Leistungsempfänger zu zeigen.
- None.
- None.
FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 4:30 p.m. Eastern Time.
A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
When is Clover Health (CLOV) presenting at the 2024 Wells Fargo Healthcare Conference?
Who will be representing Clover Health (CLOV) at the 2024 Wells Fargo Healthcare Conference?
How can investors access Clover Health's (CLOV) presentation at the 2024 Wells Fargo Healthcare Conference?
What is Clover Health's (CLOV) focus as a company?
